Key facts
- Peytant Solutions’s last known valuation is $9.2M (Jul 2017).
- It has raised $5.8M across 4 recorded rounds; the latest was Seed Round ($2.9M) in Feb 2023.
- Notable investors include Robert Thatcher, Steven Healy.
- Peytant Solutions has filed 7 Form Ds with the SEC since 2015, most recently Jan 2025 ($2.9M sold to 19 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Peytant Solutions
Funding rounds
4 roundsAbout Peytant Solutions
Developer of a medical implant designed to offer rapid bio-integration in the treatment of all luminal diseases. The company's implant incorporates regenerative human biomaterials with absorbable and alloy implant technologies and offers a regenerative human biomaterial platform for the treatment of luminal diseases, enabling doctors to treat them with a high success rate.
- Sector
- Healthcare
- HQ
- Plymouth, MN, United States
- Founded
- 2008
- Employees
- 13
- Website
- peytant.com/
- Ownership
- Privately Held (backing)
Peytant Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Peytant Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Peytant Solutions in its N-PORT filings yet. We sweep new filings monthly.